Janssen reports positive long-term results from Phase III trial of sirukumab for RA

Janssen-Cilag International (Janssen) has reported positive long-term results from the Phase III SIRROUND-T clinical trial of sirukumab to treat patients with rheumatoid arthritis (RA).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news